RACHEL SCHIFF

Concepts (496)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
127
2025
2519
11.380
Why?
Drug Resistance, Neoplasm
62
2025
733
7.790
Why?
Receptor, ErbB-2
53
2025
514
7.520
Why?
Receptors, Estrogen
57
2024
794
6.580
Why?
Antineoplastic Agents, Hormonal
38
2022
257
4.480
Why?
Estrogen Receptor alpha
21
2022
458
3.470
Why?
Tamoxifen
35
2022
363
3.410
Why?
Trastuzumab
25
2025
134
2.430
Why?
Quinazolines
20
2023
175
2.310
Why?
Antineoplastic Combined Chemotherapy Protocols
15
2025
1244
2.110
Why?
Signal Transduction
55
2025
4595
2.000
Why?
Antineoplastic Agents
24
2022
1714
1.960
Why?
Gene Expression Regulation, Neoplastic
39
2024
1980
1.690
Why?
Cell Line, Tumor
56
2025
3419
1.510
Why?
ErbB Receptors
15
2020
283
1.380
Why?
Xenograft Model Antitumor Assays
26
2024
914
1.330
Why?
Receptor Cross-Talk
11
2015
38
1.290
Why?
Mice, Nude
32
2025
725
1.280
Why?
Molecular Targeted Therapy
10
2025
375
1.210
Why?
Cyclin-Dependent Kinase 4
5
2024
59
1.210
Why?
Cyclin-Dependent Kinase 6
3
2024
44
1.120
Why?
Hepatocyte Nuclear Factor 3-alpha
4
2022
48
1.100
Why?
Neoplasms, Hormone-Dependent
6
2018
101
1.080
Why?
Phosphatidylinositol 3-Kinases
9
2017
339
1.080
Why?
Estradiol
11
2022
530
1.070
Why?
Transcription Factor AP-1
5
2022
109
1.070
Why?
Genes, erbB-2
6
2013
37
1.030
Why?
Neoadjuvant Therapy
11
2023
344
1.000
Why?
PTEN Phosphohydrolase
4
2017
260
0.990
Why?
Estrogen Receptor Modulators
8
2008
38
0.980
Why?
Female
114
2025
66888
0.960
Why?
Cell Proliferation
27
2024
2372
0.890
Why?
Class I Phosphatidylinositol 3-Kinases
5
2023
74
0.880
Why?
Antineoplastic Agents, Immunological
2
2025
115
0.870
Why?
Biomarkers, Tumor
16
2024
1534
0.870
Why?
Protein Kinase Inhibitors
7
2025
543
0.860
Why?
Mice
58
2025
17744
0.850
Why?
Pyridines
3
2024
235
0.820
Why?
Piperazines
3
2024
242
0.810
Why?
Humans
140
2025
125439
0.810
Why?
Lymphocytes, Tumor-Infiltrating
2
2022
121
0.800
Why?
Estrogens
12
2022
505
0.790
Why?
Apoptosis
16
2024
1817
0.770
Why?
Animals
66
2025
34310
0.750
Why?
MCF-7 Cells
12
2021
222
0.750
Why?
Antibodies, Monoclonal, Humanized
15
2020
509
0.740
Why?
Gene Expression Profiling
12
2021
1756
0.730
Why?
Interferons
1
2022
126
0.710
Why?
Aromatase Inhibitors
6
2017
76
0.680
Why?
Precision Medicine
2
2019
321
0.650
Why?
Antibodies, Monoclonal
11
2013
1026
0.630
Why?
Prognosis
21
2025
4690
0.620
Why?
Cinnamates
1
2018
15
0.620
Why?
Circulating Tumor DNA
1
2018
35
0.590
Why?
Lymphocytes
1
2019
408
0.570
Why?
Indoles
1
2018
191
0.570
Why?
DNA, Neoplasm
2
2017
306
0.550
Why?
Proto-Oncogene Proteins c-myc
4
2024
208
0.540
Why?
Neoplastic Cells, Circulating
4
2019
74
0.530
Why?
Receptors, Growth Factor
3
2005
35
0.520
Why?
Receptors, G-Protein-Coupled
4
2025
296
0.510
Why?
Neoplastic Stem Cells
3
2019
321
0.490
Why?
Interleukin-8
1
2016
210
0.490
Why?
RNA, Small Interfering
13
2018
670
0.490
Why?
Tumor Microenvironment
4
2025
565
0.480
Why?
Chromatin
4
2022
579
0.470
Why?
Tumor Cells, Cultured
12
2021
1077
0.460
Why?
Epidermal Growth Factor
5
2021
123
0.440
Why?
Growth Substances
4
2004
113
0.440
Why?
Transcriptome
4
2016
977
0.430
Why?
Gene Amplification
5
2016
236
0.410
Why?
Mammary Neoplasms, Experimental
5
2014
246
0.410
Why?
Estrogen Antagonists
4
2022
104
0.410
Why?
Sirolimus
1
2014
227
0.400
Why?
Up-Regulation
8
2016
875
0.400
Why?
Proto-Oncogene Proteins c-bcl-2
2
2015
172
0.400
Why?
Mucin-4
1
2012
11
0.400
Why?
Receptors, Progesterone
5
2015
877
0.380
Why?
Phosphorylation
12
2021
1638
0.370
Why?
Integrin beta1
1
2011
56
0.370
Why?
Transcription, Genetic
8
2020
1705
0.370
Why?
Carcinoma, Ductal, Breast
3
2022
85
0.370
Why?
Apoptosis Regulatory Proteins
1
2012
151
0.370
Why?
Oncogene Proteins
3
2021
143
0.360
Why?
Receptor Protein-Tyrosine Kinases
3
2018
129
0.360
Why?
Mutation
12
2019
5903
0.330
Why?
Gene Expression
6
2020
1554
0.320
Why?
Carcinoma
2
2015
290
0.320
Why?
Protein Kinases
4
2016
331
0.310
Why?
Adaptation, Physiological
2
2021
270
0.310
Why?
Gold
3
2014
47
0.300
Why?
Triple Negative Breast Neoplasms
3
2018
234
0.300
Why?
Estrogen Receptor beta
3
2008
79
0.300
Why?
Epigenesis, Genetic
4
2019
702
0.300
Why?
Cell Cycle
6
2024
627
0.300
Why?
Proteome
1
2010
247
0.300
Why?
Transplantation, Heterologous
8
2011
261
0.300
Why?
TOR Serine-Threonine Kinases
5
2020
436
0.290
Why?
Proto-Oncogene Proteins c-akt
6
2017
493
0.290
Why?
Fibroblasts
5
2022
887
0.290
Why?
Mitogen-Activated Protein Kinases
3
2014
210
0.280
Why?
Carcinogenesis
4
2025
340
0.280
Why?
Chemotherapy, Adjuvant
5
2019
366
0.280
Why?
Neoplasm Transplantation
9
2019
383
0.270
Why?
Transcription Factors
5
2019
2603
0.270
Why?
Histone Acetyltransferases
4
2020
312
0.260
Why?
Cell Transformation, Neoplastic
6
2014
634
0.260
Why?
Cellular Reprogramming
2
2020
113
0.250
Why?
Neoplasm Staging
5
2025
1275
0.250
Why?
Oligonucleotide Array Sequence Analysis
5
2016
1033
0.250
Why?
Gene Knockdown Techniques
6
2018
367
0.250
Why?
Genes, erbB-1
1
2005
10
0.240
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 12
2
2018
19
0.240
Why?
Survival Analysis
4
2020
1494
0.240
Why?
RNA Interference
5
2019
508
0.230
Why?
Membrane Proteins
1
2012
1538
0.230
Why?
Nanoshells
3
2014
13
0.230
Why?
Neoplasm Proteins
2
2020
681
0.230
Why?
Enzyme Inhibitors
4
2020
587
0.220
Why?
Extracellular Matrix Proteins
1
2025
156
0.220
Why?
Heterografts
3
2022
175
0.220
Why?
Cyclin-Dependent Kinases
1
2024
89
0.220
Why?
Homeodomain Proteins
2
2019
556
0.220
Why?
Drugs, Investigational
1
2003
22
0.210
Why?
Carrier Proteins
3
2020
1034
0.210
Why?
Blotting, Western
7
2011
1109
0.210
Why?
Repressor Proteins
4
2014
826
0.210
Why?
Intercellular Signaling Peptides and Proteins
4
2014
283
0.200
Why?
Neoplasm Metastasis
5
2017
705
0.200
Why?
Drug Resistance
2
2018
256
0.200
Why?
Carcinoma, Lobular
1
2022
24
0.200
Why?
Treatment Outcome
14
2025
12303
0.200
Why?
GATA3 Transcription Factor
2
2020
35
0.200
Why?
Clonal Evolution
2
2021
41
0.200
Why?
Phototherapy
2
2014
35
0.190
Why?
Middle Aged
16
2025
26827
0.190
Why?
Receptors, Neuropeptide Y
1
2022
8
0.190
Why?
Endocrine Gland Neoplasms
1
2022
6
0.190
Why?
Drug Synergism
2
2016
227
0.190
Why?
Promoter Regions, Genetic
5
2019
1338
0.190
Why?
Enhancer of Zeste Homolog 2 Protein
2
2021
63
0.190
Why?
F-Box Proteins
2
2019
35
0.180
Why?
src-Family Kinases
4
2020
91
0.180
Why?
Selective Estrogen Receptor Modulators
4
2022
60
0.170
Why?
Proto-Oncogene Proteins
2
2021
559
0.170
Why?
p300-CBP Transcription Factors
1
2020
43
0.170
Why?
Aged
14
2025
19739
0.170
Why?
Nuclear Proteins
4
2020
1284
0.170
Why?
Protein-Arginine N-Methyltransferases
1
2020
43
0.170
Why?
Cell Survival
6
2021
820
0.160
Why?
Thiophenes
1
2020
69
0.160
Why?
Mevalonic Acid
1
2019
19
0.160
Why?
Single-Cell Analysis
2
2020
288
0.160
Why?
Keratins
2
2019
54
0.160
Why?
NF-kappa B
1
2022
462
0.160
Why?
SOXB1 Transcription Factors
1
2019
60
0.160
Why?
Phenotype
9
2016
4269
0.160
Why?
Proteogenomics
1
2020
69
0.160
Why?
Bone and Bones
1
2021
266
0.160
Why?
Dendritic Cells
1
2022
414
0.160
Why?
Trans-Activators
1
2003
801
0.150
Why?
Integrin alpha6
1
2018
5
0.150
Why?
Oncogene Proteins, Fusion
1
2020
214
0.150
Why?
Mice, SCID
3
2019
586
0.150
Why?
Protein-Tyrosine Kinases
4
2024
214
0.150
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2025
730
0.150
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2018
35
0.150
Why?
Flavonoids
1
2018
77
0.140
Why?
Receptors, Aryl Hydrocarbon
1
2018
64
0.140
Why?
RNA, Messenger
6
2010
2812
0.140
Why?
Proteomics
2
2013
507
0.140
Why?
Adult
14
2025
29635
0.140
Why?
Lasers
2
2014
114
0.140
Why?
Protein Binding
5
2020
1755
0.130
Why?
Disease Models, Animal
8
2021
4405
0.130
Why?
SOX9 Transcription Factor
1
2017
82
0.130
Why?
Cytokines
1
2022
1288
0.130
Why?
Receptors, Cell Surface
1
2018
477
0.120
Why?
Oxidative Stress
1
2000
818
0.120
Why?
Receptor, ErbB-4
1
2015
8
0.120
Why?
Chlorophyll
1
2014
4
0.120
Why?
Drug Liberation
1
2014
12
0.120
Why?
Tumor Burden
2
2014
231
0.120
Why?
Mice, Inbred NOD
2
2013
299
0.120
Why?
Genomic Instability
1
2016
230
0.120
Why?
Immunohistochemistry
5
2015
1703
0.120
Why?
Photochemistry
1
2014
22
0.110
Why?
Ribonucleoside Diphosphate Reductase
1
2014
12
0.110
Why?
Mice, Inbred BALB C
3
2019
1001
0.110
Why?
Mitochondrial Proteins
2
2013
228
0.110
Why?
Genes, myc
2
2011
104
0.110
Why?
Cell Differentiation
1
2022
1908
0.110
Why?
Nanotechnology
1
2014
46
0.110
Why?
MAP Kinase Kinase Kinase 3
1
2014
9
0.110
Why?
Hyperthermia, Induced
1
2014
54
0.110
Why?
Mammary Neoplasms, Animal
2
2005
139
0.110
Why?
Liposomes
1
2014
188
0.110
Why?
Metal Nanoparticles
1
2014
41
0.110
Why?
Doxycycline
1
2014
117
0.110
Why?
Phosphatidylinositols
1
2013
31
0.110
Why?
Glutarates
1
2013
37
0.110
Why?
Down-Regulation
5
2021
691
0.110
Why?
Acneiform Eruptions
1
2013
4
0.110
Why?
Cell Membrane
2
2013
464
0.110
Why?
Nuclear Receptor Coactivator 3
3
2010
348
0.100
Why?
Neoplasms
3
2014
2800
0.100
Why?
Follow-Up Studies
2
2019
5174
0.100
Why?
DNA Mutational Analysis
1
2015
809
0.100
Why?
Drug Eruptions
1
2013
32
0.100
Why?
Random Allocation
1
2014
439
0.100
Why?
Proto-Oncogene Proteins c-ets
1
2013
57
0.100
Why?
Histone-Lysine N-Methyltransferase
1
2014
161
0.100
Why?
Cytoplasm
2
2011
296
0.100
Why?
Tumor Suppressor Proteins
3
2011
472
0.100
Why?
Heat-Shock Proteins
1
2013
196
0.100
Why?
Genomics
1
2020
1520
0.100
Why?
Gene Rearrangement
1
2014
323
0.100
Why?
CD24 Antigen
1
2012
31
0.100
Why?
Mammary Glands, Human
2
2010
79
0.100
Why?
Hyaluronan Receptors
1
2012
66
0.100
Why?
Models, Biological
3
2008
1466
0.100
Why?
Kaplan-Meier Estimate
3
2025
1065
0.100
Why?
Ubiquitin-Activating Enzymes
1
2011
23
0.090
Why?
Lung Neoplasms
2
2019
1654
0.090
Why?
Focal Adhesion Kinase 1
1
2011
25
0.090
Why?
Paclitaxel
1
2012
130
0.090
Why?
Mitogen-Activated Protein Kinase 3
2
2010
92
0.090
Why?
Statistics, Nonparametric
1
2012
434
0.090
Why?
Mitogen-Activated Protein Kinase 1
2
2010
108
0.090
Why?
cdc42 GTP-Binding Protein
1
2010
31
0.090
Why?
Eukaryotic Initiation Factor-3
1
2010
8
0.090
Why?
Insulin-Like Growth Factor I
2
2010
340
0.090
Why?
Lentivirus
1
2011
82
0.090
Why?
Diagnostic Imaging
2
2011
280
0.090
Why?
Ovariectomy
2
2008
183
0.090
Why?
Antigens, Viral, Tumor
1
2010
47
0.090
Why?
Polyomavirus
1
2010
32
0.090
Why?
Genetic Techniques
1
2011
107
0.090
Why?
Receptor, IGF Type 1
2
2008
92
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
1293
0.090
Why?
Tumor Necrosis Factor-alpha
2
2014
682
0.080
Why?
Protein Processing, Post-Translational
2
2011
360
0.080
Why?
Cell Division
3
2007
780
0.080
Why?
Antibodies
1
2011
374
0.080
Why?
Immunoconjugates
1
2010
38
0.080
Why?
Proto-Oncogene Proteins p21(ras)
1
2010
158
0.080
Why?
Aged, 80 and over
7
2019
6558
0.080
Why?
Proteasome Endopeptidase Complex
1
2010
262
0.080
Why?
MAP Kinase Kinase 5
1
2008
3
0.080
Why?
Mitogen-Activated Protein Kinase 7
1
2008
9
0.080
Why?
Triazoles
3
2015
140
0.080
Why?
Gene Silencing
3
2016
241
0.080
Why?
Mesoderm
1
2008
108
0.080
Why?
Reproducibility of Results
4
2020
2904
0.070
Why?
Receptors, CXCR4
1
2008
57
0.070
Why?
Transfection
4
2013
1076
0.070
Why?
Heparin-binding EGF-like Growth Factor
1
2008
14
0.070
Why?
Endocrine System
1
2008
22
0.070
Why?
Nanoparticles
1
2010
230
0.070
Why?
Epithelium
1
2008
365
0.070
Why?
Indium Radioisotopes
1
2007
9
0.070
Why?
Protein Biosynthesis
1
2010
665
0.070
Why?
Laser Therapy
1
2010
249
0.070
Why?
Genetic Vectors
1
2011
940
0.070
Why?
Organometallic Compounds
1
2007
111
0.070
Why?
Radiopharmaceuticals
1
2007
168
0.070
Why?
Neoplasm Recurrence, Local
3
2022
1156
0.070
Why?
Gene Dosage
1
2008
445
0.060
Why?
Receptors, Somatotropin
1
2006
9
0.060
Why?
Carcinoma, Renal Cell
1
2008
240
0.060
Why?
Cell Separation
2
2019
230
0.060
Why?
Clinical Trials as Topic
1
2011
1104
0.060
Why?
Clinical Trials, Phase II as Topic
2
2020
73
0.060
Why?
Polyamines
1
2005
28
0.060
Why?
Human Growth Hormone
1
2006
74
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2008
560
0.060
Why?
Disease-Free Survival
3
2015
880
0.060
Why?
Cell Cycle Proteins
3
2014
664
0.060
Why?
Laminin
1
2025
69
0.060
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
126
0.060
Why?
Silicon Dioxide
2
2014
24
0.060
Why?
DNA Methylation
3
2017
1051
0.060
Why?
Protein Kinase C
1
2005
149
0.060
Why?
JNK Mitogen-Activated Protein Kinases
2
2002
88
0.060
Why?
Particle Size
2
2014
124
0.060
Why?
Kidney Neoplasms
1
2008
440
0.060
Why?
Genome-Wide Association Study
1
2011
1694
0.050
Why?
Proportional Hazards Models
3
2015
1361
0.050
Why?
Forecasting
1
2005
352
0.050
Why?
Nitriles
2
2015
146
0.050
Why?
Drug Evaluation, Preclinical
1
2003
155
0.050
Why?
Receptors, Retinoic Acid
1
2003
100
0.050
Why?
Acetyltransferases
1
2003
89
0.050
Why?
Neoplasm Invasiveness
2
2015
625
0.050
Why?
Nuclear Receptor Coactivator 1
1
2003
238
0.050
Why?
Polyethylene Glycols
2
2014
240
0.050
Why?
Tissue Array Analysis
2
2014
137
0.050
Why?
Genetic Predisposition to Disease
1
2013
3175
0.050
Why?
Computational Biology
2
2020
819
0.050
Why?
Cadherins
1
2003
172
0.050
Why?
Tetrahydronaphthalenes
1
2022
29
0.050
Why?
Phosphatidylinositol 3-Kinase
1
2021
25
0.050
Why?
Resting Phase, Cell Cycle
1
2021
16
0.050
Why?
CRISPR-Cas Systems
1
2024
257
0.050
Why?
Metabolome
2
2014
292
0.050
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2021
61
0.050
Why?
Neoplasm Micrometastasis
1
2021
13
0.050
Why?
Dose-Response Relationship, Drug
2
2021
1692
0.050
Why?
Cell Cycle Checkpoints
1
2021
57
0.050
Why?
Gap Junctions
1
2021
38
0.050
Why?
G1 Phase
1
2021
67
0.040
Why?
Chloramphenicol O-Acetyltransferase
1
2000
79
0.040
Why?
Proto-Oncogene Proteins c-jun
1
2000
39
0.040
Why?
Pentose Phosphate Pathway
1
2000
43
0.040
Why?
Cell Line
3
2011
2755
0.040
Why?
Gene Ontology
1
2020
46
0.040
Why?
Cell Movement
2
2014
854
0.040
Why?
Lipid Peroxidation
1
2000
96
0.040
Why?
Lymphatic Metastasis
2
2013
418
0.040
Why?
Dasatinib
1
2020
41
0.040
Why?
Cell Communication
1
2021
167
0.040
Why?
Glutathione Transferase
1
2000
156
0.040
Why?
Genes, Reporter
1
2021
381
0.040
Why?
Molecular Conformation
1
2020
107
0.040
Why?
Osteogenesis
1
2021
154
0.040
Why?
Superoxide Dismutase
1
2000
181
0.040
Why?
Flow Cytometry
2
2014
802
0.040
Why?
Biopsy, Large-Core Needle
1
2020
31
0.040
Why?
Clinical Trials, Phase III as Topic
1
2020
69
0.040
Why?
Green Fluorescent Proteins
1
2021
387
0.040
Why?
Acetylation
1
2020
168
0.040
Why?
Gonadal Steroid Hormones
1
2020
87
0.040
Why?
Molecular Docking Simulation
1
2020
110
0.040
Why?
Protein Isoforms
3
2008
404
0.040
Why?
Cyclopentanes
1
2019
20
0.040
Why?
Fluorescent Antibody Technique
2
2011
461
0.040
Why?
Molecular Structure
1
2020
295
0.040
Why?
Enzyme Activation
2
2010
626
0.040
Why?
Remission Induction
1
2020
292
0.040
Why?
Epithelial Cells
2
2014
909
0.040
Why?
Leukocyte Common Antigens
1
2019
91
0.040
Why?
Mice, Knockout
2
2019
3754
0.040
Why?
Ubiquitination
1
2019
170
0.040
Why?
Structure-Activity Relationship
1
2020
581
0.040
Why?
Drug Discovery
1
2020
171
0.040
Why?
Mice, Transgenic
3
2010
2414
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
166
0.040
Why?
Oncogene Protein v-akt
1
2018
30
0.040
Why?
Transcriptional Activation
1
2020
486
0.040
Why?
Drug Administration Schedule
2
2013
730
0.040
Why?
Time Factors
3
2015
6324
0.040
Why?
Oncogene Addiction
1
2017
3
0.040
Why?
Predictive Value of Tests
1
2003
2183
0.030
Why?
Benzimidazoles
1
2018
134
0.030
Why?
Adaptor Proteins, Signal Transducing
2
2014
560
0.030
Why?
Ligands
1
2018
538
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2016
6
0.030
Why?
Extracellular Signal-Regulated MAP Kinases
2
2008
145
0.030
Why?
MAP Kinase Signaling System
2
2011
314
0.030
Why?
Pyrimidines
1
2019
377
0.030
Why?
Bone Neoplasms
1
2021
427
0.030
Why?
Microscopy, Confocal
2
2010
349
0.030
Why?
Cell Nucleus
1
2019
680
0.030
Why?
Epithelial-Mesenchymal Transition
1
2017
216
0.030
Why?
Breast
1
2017
213
0.030
Why?
Models, Molecular
1
2019
1084
0.030
Why?
DNA, Complementary
2
2011
463
0.030
Why?
Pilot Projects
1
2020
1399
0.030
Why?
Drug Design
1
2016
153
0.030
Why?
Fluoresceins
1
2014
35
0.030
Why?
Luminescent Measurements
1
2014
56
0.030
Why?
Immunoblotting
1
2015
312
0.030
Why?
Lasers, Semiconductor
1
2014
9
0.030
Why?
Photochemotherapy
1
2014
35
0.030
Why?
Nanomedicine
1
2014
14
0.030
Why?
Transducers
1
2014
24
0.030
Why?
Survival Rate
1
2019
2050
0.030
Why?
Ki-67 Antigen
1
2014
114
0.030
Why?
Surface Properties
1
2014
83
0.030
Why?
Materials Testing
1
2014
72
0.030
Why?
Light
1
2014
176
0.030
Why?
Injections, Intravenous
1
2014
248
0.030
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2014
23
0.030
Why?
Tissue Distribution
1
2014
391
0.030
Why?
Alcohol Oxidoreductases
1
2013
20
0.030
Why?
Colony-Forming Units Assay
1
2014
70
0.030
Why?
Open Reading Frames
1
2014
212
0.030
Why?
Azepines
1
2014
64
0.030
Why?
Disease Progression
2
2013
2083
0.030
Why?
Proteolysis
1
2014
172
0.030
Why?
Solubility
1
2013
139
0.030
Why?
Etoposide
1
2014
115
0.030
Why?
Fluorouracil
1
2014
129
0.030
Why?
Culture Media, Serum-Free
2
2003
22
0.030
Why?
fas Receptor
1
2013
41
0.030
Why?
Nuclear Receptor Co-Repressor 1
2
2003
54
0.030
Why?
Epigenomics
1
2014
176
0.030
Why?
DNA Damage
1
2016
516
0.030
Why?
Optics and Photonics
1
2014
139
0.030
Why?
Isocitrate Dehydrogenase
1
2013
78
0.030
Why?
Mass Spectrometry
1
2014
335
0.030
Why?
Sequence Analysis, DNA
1
2019
1763
0.030
Why?
In Vitro Techniques
1
2014
972
0.020
Why?
Doxorubicin
1
2014
288
0.020
Why?
Plasmids
1
2013
513
0.020
Why?
Glutamine
1
2013
215
0.020
Why?
Wnt Signaling Pathway
1
2013
193
0.020
Why?
In Situ Hybridization, Fluorescence
1
2014
772
0.020
Why?
Sequence Analysis, RNA
1
2014
371
0.020
Why?
Spindle Apparatus
1
2011
63
0.020
Why?
Sumoylation
1
2011
37
0.020
Why?
Image Processing, Computer-Assisted
1
2014
586
0.020
Why?
Immunoenzyme Techniques
1
2011
259
0.020
Why?
Luminescence
1
2011
16
0.020
Why?
Foreskin
1
2010
3
0.020
Why?
Mitosis
1
2011
241
0.020
Why?
Electromagnetic Fields
1
2010
27
0.020
Why?
F-Box-WD Repeat-Containing Protein 7
1
2010
21
0.020
Why?
Polyribosomes
1
2010
25
0.020
Why?
NIH 3T3 Cells
1
2010
92
0.020
Why?
Multicenter Studies as Topic
1
2011
275
0.020
Why?
Taxoids
1
2010
67
0.020
Why?
Fluorescence
1
2010
96
0.020
Why?
Recombinant Fusion Proteins
1
2013
772
0.020
Why?
Sphingosine
1
2010
12
0.020
Why?
Metabolomics
1
2014
422
0.020
Why?
Lysophospholipids
1
2010
28
0.020
Why?
Histones
1
2014
542
0.020
Why?
Placebos
1
2011
241
0.020
Why?
Guanine Nucleotide Exchange Factors
1
2010
92
0.020
Why?
Frozen Sections
1
2010
26
0.020
Why?
Phosphotransferases (Alcohol Group Acceptor)
1
2010
74
0.020
Why?
RNA-Binding Proteins
1
2014
578
0.020
Why?
Ribosomes
1
2010
137
0.020
Why?
p21-Activated Kinases
1
2010
57
0.020
Why?
Spectroscopy, Near-Infrared
1
2010
145
0.020
Why?
Genome, Human
1
2016
1293
0.020
Why?
Fluorine Radioisotopes
1
2009
11
0.020
Why?
Dideoxynucleosides
1
2009
9
0.020
Why?
Algorithms
1
2016
1633
0.020
Why?
Cellular Senescence
1
2010
163
0.020
Why?
Cell Death
1
2010
240
0.020
Why?
Tumor Stem Cell Assay
1
2008
34
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2008
42
0.020
Why?
S-Phase Kinase-Associated Proteins
1
2008
16
0.020
Why?
Prospective Studies
2
2013
6174
0.020
Why?
Mitochondria
1
2013
679
0.020
Why?
Multivariate Analysis
1
2012
1430
0.020
Why?
Cyclin D1
1
2008
113
0.020
Why?
Fluorodeoxyglucose F18
1
2009
147
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2011
261
0.020
Why?
Chromatography, Liquid
1
2008
199
0.020
Why?
Ubiquitin-Protein Ligases
1
2010
359
0.020
Why?
Genes, Tumor Suppressor
1
2008
214
0.020
Why?
Mammary Glands, Animal
1
2011
478
0.020
Why?
Positron-Emission Tomography
1
2009
306
0.020
Why?
Logistic Models
1
2012
1808
0.020
Why?
Tomography, Emission-Computed, Single-Photon
1
2007
107
0.020
Why?
Tandem Mass Spectrometry
1
2008
234
0.020
Why?
Src Homology 2 Domain-Containing, Transforming Protein 1
1
2005
2
0.020
Why?
Dendrimers
1
2005
5
0.020
Why?
Biomarkers
1
2015
3104
0.020
Why?
Shc Signaling Adaptor Proteins
1
2005
12
0.020
Why?
Rhodamines
1
2005
23
0.020
Why?
Binding, Competitive
1
2005
192
0.020
Why?
Young Adult
1
2019
9085
0.020
Why?
Mitogens
1
2005
31
0.020
Why?
Acetophenones
1
2005
13
0.020
Why?
Benzopyrans
1
2005
21
0.020
Why?
Protein Kinase C-delta
1
2005
17
0.020
Why?
Wnt1 Protein
1
2005
71
0.010
Why?
Confidence Intervals
1
2005
283
0.010
Why?
Phosphoric Monoester Hydrolases
1
2005
102
0.010
Why?
Glucose
1
2009
878
0.010
Why?
Genes, p53
1
2005
217
0.010
Why?
Extracellular Matrix
1
2005
238
0.010
Why?
Wnt Proteins
1
2005
216
0.010
Why?
MicroRNAs
1
2011
855
0.010
Why?
Microscopy, Fluorescence
1
2005
330
0.010
Why?
Infusions, Intravenous
1
2005
554
0.010
Why?
Cell Line, Transformed
1
2003
169
0.010
Why?
Age Factors
1
2010
2828
0.010
Why?
Antibody Specificity
1
2003
204
0.010
Why?
Genome
1
2005
481
0.010
Why?
Genes, Dominant
1
2003
244
0.010
Why?
Antigens, Neoplasm
1
2005
384
0.010
Why?
Odds Ratio
1
2005
1253
0.010
Why?
Kidney
1
2008
1363
0.010
Why?
Biopsy
1
2005
1243
0.010
Why?
DNA
1
2005
1619
0.010
Why?
Tomography, X-Ray Computed
1
2007
2091
0.010
Why?
Magnetic Resonance Imaging
1
2010
3603
0.010
Why?
Gene Expression Regulation
1
2005
2524
0.010
Why?
Osteosarcoma
1
1999
255
0.010
Why?
Retrospective Studies
1
2011
16362
0.010
Why?
Male
1
2010
61628
0.000
Why?
SCHIFF's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (496)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_